Clinical trial
Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
NCT03224221 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Anhui Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
- Lead sponsor
- The First Affiliated Hospital of Anhui Medical University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 23, 2017
- Completion date
- June 23, 2019
- Enrollment
- 189 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.